Abbott’s Panbio Rapid Antigen Test Receives CE Mark for Mass COVID-19 Screening
Shots: Celenex (a Nationwide Children Hospital spin out) to receive an upfront of $100M cash, development milestones up to $15M, and may be eligible for up to $75M tiered sales ($500M /$750M) milestone payments with no royalties, $262M for BLA/MAA submission and approval milestones across multiple programs Amicus will not pay >$75M over the next […]Read More
